CBLN1 and Alzheimer disease: About comparing between healthy controls and non-AD with comorbidities group, serum levels of four variants of LPE, lyso-platelet-activating factor, and Cer(16:0) were decreased in non-AD with atopic comorbidities group compared with that in healthy controls (Table 1 and Figure 1).